XML 31 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Notes to the consolidated statements of income (Tables)
9 Months Ended
Sep. 30, 2020
Notes to the consolidated statements of income  
Schedule of revenue

 

Revenue

in € THOUS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended

 

 

September 30, 

 

 

2020

 

2019

 

 

Revenue from

 

 

 

 

 

Revenue from

 

 

 

 

 

 

contracts with

 

Other 

 

 

 

contracts with

 

Other

 

 

 

    

customers

    

revenue

    

Total

    

customers

    

revenue

    

Total

Health care services

 

 

 

 

 

 

 

 

 

 

 

 

Dialysis services

 

3,099,844

 

 —

 

3,099,844

 

3,155,050

 

 —

 

3,155,050

Care Coordination

 

327,560

 

72,033

 

399,593

 

271,307

 

65,959

 

337,266

 

 

3,427,404

 

72,033

 

3,499,437

 

3,426,357

 

65,959

 

3,492,316

 

 

 

 

 

 

 

 

 

 

 

 

 

Health care products

 

 

 

 

 

 

 

 

 

 

 

 

Dialysis products

 

866,144

 

24,459

 

890,603

 

877,008

 

29,869

 

906,877

Non-dialysis products

 

23,728

 

 —

 

23,728

 

19,810

 

 —

 

19,810

 

 

889,872

 

24,459

 

914,331

 

896,818

 

29,869

 

926,687

Total

 

4,317,276

 

96,492

 

4,413,768

 

4,323,175

 

95,828

 

4,419,003

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the nine months ended

 

 

September 30, 

 

 

2020

 

2019

 

 

Revenue from

 

 

 

 

 

Revenue from

 

 

 

 

 

 

contracts with

 

Other

 

 

 

contracts with

 

Other

 

 

 

    

customers

    

revenue

    

Total

    

customers

    

revenue

    

Total

Health care services

 

  

 

  

 

  

 

  

 

  

 

  

Dialysis services

 

9,522,094

 

 —

 

9,522,094

 

9,232,698

 

 —

 

9,232,698

Care Coordination

 

955,851

 

230,024

 

1,185,875

 

849,788

 

182,335

 

1,032,123

 

 

10,477,945

 

230,024

 

10,707,969

 

10,082,486

 

182,335

 

10,264,821

Health care products

 

 

 

 

 

 

 

 

 

 

 

 

Dialysis products

 

2,599,606

 

75,720

 

2,675,326

 

2,479,262

 

96,756

 

2,576,018

Non-dialysis products

 

75,614

 

 —

 

75,614

 

55,753

 

 —

 

55,753

 

 

2,675,220

 

75,720

 

2,750,940

 

2,535,015

 

96,756

 

2,631,771

Total

 

13,153,165

 

305,744

 

13,458,909

 

12,617,501

 

279,091

 

12,896,592

 

Schedule of reconciliation of basic and diluted earnings per share

 

Reconciliation of basic and diluted earnings per share

in € THOUS, except share and per share data

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended

 

For the nine months ended

 

 

September 30, 

 

September 30, 

 

    

2020

    

2019

    

2020

    

2019

Numerator:

 

  

 

  

 

  

 

  

Net income attributable to shareholders of FMC-AG & Co. KGaA

 

353,502

 

332,584

 

987,193

 

857,113

 

 

 

 

 

 

 

 

 

Denominators:

 

 

 

 

 

 

 

 

Weighted average number of shares outstanding

 

292,817,296

 

301,440,412

 

294,458,296

 

303,832,868

Potentially dilutive shares

 

251,979

 

 —

 

230,751

 

83,518

Basic earnings per share

 

1.21

 

1.10

 

3.35

 

2.82

Diluted earnings per share

 

1.21

 

1.10

 

3.35

 

2.82

 

Schedule of number of shares acquired in the context of the buy-back programs as well as the repurchased treasury stock

 

 

 

 

 

 

 

 

 

 

 

Total number of shares

 

 

 

 

 

 

purchased and retired

 

 

 

 

 

 

as part of publicly

 

 

 

 

Average price per

 

announced plans or

 

Total value of

Period

    

share

    

programs

    

shares (1)

 

    

in €

    

 

    

in € THOUS

December 31, 2018

 

51.00

 

999,951

 

50,993

Purchase of Treasury Stock

 

 

 

 

 

 

March 2019

 

69.86

 

1,629,240

 

113,816

April 2019

 

72.83

 

1,993,974

 

145,214

May 2019

 

72.97

 

147,558

 

10,766

Repurchased Treasury Stock

 

71.55

 

3,770,772

 

269,796

 

 

 

 

 

 

 

Retirement of repurchased Treasury Stock

 

 

 

 

 

 

June 2019

 

71.55

 

3,770,772

 

269,796

 

 

 

 

 

 

 

Purchase of Treasury Stock

 

 

 

 

 

 

June 2019

 

67.11

 

504,672

 

33,870

July 2019

 

66.77

 

1,029,655

 

68,748

August 2019

 

57.53

 

835,208

 

48,050

September 2019

 

59.67

 

627,466

 

37,445

October 2019

 

57.85

 

692,910

 

40,084

November 2019

 

64.78

 

852,859

 

55,245

December 2019

 

63.85

 

564,908

 

36,067

Repurchased Treasury Stock

 

62.55

 

5,107,678

 

319,509

December 31, 2019

 

60.66

 

6,107,629

 

370,502

 

 

 

 

 

 

 

Purchase of Treasury Stock

 

  

 

  

 

  

January 2020

 

84.37

 

124,398

 

10,495

February 2020 (2)

 

249.10

 

25,319

 

6,307

March 2020

 

63.05

 

4,842,943

 

305,362

April 2020

 

63.07

 

694,813

 

43,824

Repurchased Treasury Stock 

 

64.35

 

5,687,473

 

365,988

TOTAL 

 

62.44

 

11,795,102

 

736,490


(1)

The value of shares previously repurchased and included above as of December 31, 2018 is inclusive of fees (net of taxes) paid in the amount of approximately €11 (in € THOUS) for services rendered.

(2)

The purchase price of the shares of the program beginning on June 17, 2019 is based on the volume weighted average price of the Company's shares for the period and changes in the volume weighted average price resulted in retroactive adjustments to the purchase price, even if no shares were purchased. The February adjustment, in combination with lower shares purchased, resulted in a particularly high average price per share for the month.

Schedule that shows the amounts by which the key assumptions would need to change individually that the recoverable amount equals the carrying amount

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key assumptions

 

 

 

 

 

 

 

 

 

Sensitivity analysis

 

 

 

 

in %

 

 

 

Latin America

 

Change in percentage points

 

Latin America

 

    

2020

    

2019

    

 

    

2020

    

2019

Pre-tax WACC

 

11.90

-

25.57

 

10.45

-

20.02

 

Pre-tax WACC

 

0.22

 

1.87

After-tax WACC

 

8.83

-

22.50

 

8.06

-

17.63

 

After-tax WACC

 

0.15

 

1.24